UTRSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 00:21):

Stats
本日の出来高	10.00
平均出来高	2 403.00
時価総額	8 879.00
EPS	$0 ( 2024-03-19 )
次の収益日	( $0 ) 2024-04-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Cohen Daniel	Buy	0	Common Stock
2023-02-09	New Enterprise Associates 13 Lp	Buy	24 437 927	Common Stock
2023-02-09	Accelmed Partners Ii L.p.	Sell	0	Common Stock
2023-02-09	Geiger Uri	Buy	0	Common Stock
2023-01-02	Usen Todd	Buy	0

INSIDER POWER
100.00
Last 92 transactions
Buy: 38 540 336 \| Sell: 1 194 556

Minerva Surgical, Inc. 相関

10 最も正の相関
TLGT	0.867
HOWL	0.865
SVAC	0.852
GOODM	0.851
IVA	0.844
NLTX	0.841
MTSL	0.839
VINC	0.839
NVFY	0.837
NSTG	0.833

10 最も負の相関
AMRB	-0.912
LWAC	-0.884
SRAC	-0.841
NETE	-0.831
FLMN	-0.827
LMRKN	-0.822
MMAC	-0.813

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Minerva Surgical, Inc. 財務諸表

Annual	2022
収益:	$50.29M
総利益:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2022
収益:	$50.29M
総利益:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2021
収益:	$52.10M
総利益:	$30.52M (58.58 %)
EPS:	$-1.158

FY	2020
収益:	$37.77M
総利益:	$19.12M (50.62 %)
EPS:	$-1.090

Financial Reports:

No articles found.

Minerva Surgical, Inc.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

リアルタイムの更新： Minerva Surgical, Inc. [UTRS]

Upcoming Earnings Alert